Dow Biomedica is an expert in the field of in vitro diagnostic medical devices and serves as an IVD-Platform that integrates new technologies into the medical frontline.
The in vitro diagnostic medical device sector is a rapidly growing market resulting from the convergence of basic science and medicine. This industry continues to grow quickly as new products are continuously introduced with advancements in fundamental technologies.
By considering the nature of the industry, Dow has developed the capabilities necessary to create new markets rather than compete in existing markets, and has been recognized as the best in the industry at market development for the past 20 years.
Dow's most important mission is to improve the quality of health care services through products that utilize cutting-edge technology.
To this end, we are faithfully fulfilling our role as a market developer by introducing products from leading medical technology manufacturers around the globe to Korea and using our expertise to perform the necessary clinical trials, acquire licenses, undertake academic promotion, and provide customer support.
The D in the Dow logo symbolizes Diagnostics, Dedicated, and DNA.
The blue-green gradation of the logo symbolizes the win-win principle governing the relationship between manufacturers and customers through the circular gradation of the bio platform.
The company name, Dow, when written in Korean (茶友),
can be construed to mean “tea buddies”.
This means that we hope to become a trustworthy friend who shares
emotional connections with our customers and with the market.
Strategic Intent
MISSION
Dow contributes to improving human health through new biomarkers and cutting-edge technology.
VISION
Dow is a leading market developer in the up-and-coming in vitro diagnostic medical device market, delivering enhanced value to both customers and partners.
Key numbers
0
The 1st and the only one product
0
Years history since 2004
0
Millions US$ turnover in 2023
0
Staffs working
Do it Art!
Our 20th anniversary is special because it marks the beginning of a new era for Dow.
“Do it Art” is a slogan that symbolizes Dow’s corporate culture and is imbued with the meaning “Work like an artist and create works of art”.
The artist is a symbol of “creativity”, the core spirit of Dow’s people, and also evokes the image of “market developer”, Dow’s core competency.
By encouraging our people to apply the perspective and attitude of an artist in their everyday work, it shows the will to produce creative and original results that far exceed simple work.
This phrase, which can be interpreted as meaning "Let's work like an artist" or "Let's make art”,
is a very inspirational slogan that emphasizes creativity, passion, and artistic sensibility.
Location
-
주소서울특별시 송파구 양산로29 다우빌딩 2, 3, 4, 5, 6층
-
연결- 전화+82-2-2201-3602~3
- 팩스+82-2-2201-2166
- 이메일contact@dowbiomedica.co.kr
-
오시는길지하철거여역 7번 출구에서 위례동 방향으로 150m (도보 3분)거리
버스거여역 7번 출구 정류장 (3313번), 거여역 현대아파트 정류장 (3217, 3313, 3318, 3416번)
2021~
- 2024. 0720th anniversary of incorporation
- 2023. 11Held the 2023 Vysis User Seminar (SETEC Convention Center, Daechi-dong, Seoul)
- 2023. 07Received the Binding Site Outstanding Contribution Award 2022 (UK)
- 2023. 03Received the Illumina Elite Partner Award 2022 (USA)
- 2022. 10Supplied gastric health serum test diagnostic reagent (GastroPanel from BioHit) to medical check centers
- 2022. 07Established Healthcare Business Division
- 2021. 03Appointed first external auditor (to audit 2020) – Disclosed audit report via the Financial Supervisory Service electronic disclosure system
2015~
- 2020. 11Endocrine hormone and peptide test reagents approved by the Ministry of Food and Drug Safety (GastroPanel - Pepsinogen Ⅰ, etc.)
- 2020. 05Supplied COVID-19 antigen rapid diagnostic kit (From Celltrion)
- 2018. 11Concluded molecular product sales agency contract with Abbott, USA
- 2018. 08Supplied Triage product line from Quidel, USA
- 2018. 07Established Bio Discovery Co., Ltd., an affiliate company (Incorporated as a separate company)
- 2016. 11Concluded sales agency agreement for with Illumina, USA to supply NGS reagents and equipment
- 2016. 08Relocated head office to Dow Building, 29 Yangsan-ro, Songpa-gu, Seoul
2010~
- 2013. 12Quidel’s Sofia Influenza test reagent certified as “new medical technology” (NECA)
- 2011. 01Moved offices to 4th Floor, Sejong Building, 115-2 Ogeum-dong, Songpa-gu, Seoul
2004~
- 2009. 03Multiple myeloma diagnostic reagent Freelite (imported from Binding Site) certified as “new medical technology” (NECA)
- 2008 .03Supplied companion diagnostic test Vysis FISH (imported from Abbott, USA)
- 2007 .10Moved offices to 600-2, Jayang 2-dong, Gwangjin-gu, Seoul
- 2006. 06Incorporated as Dow Biomedica Co., Ltd. (CEO Shin Young-gil)
- 2004. 07Dow Biomedica founded as sole proprietorship importing medical devices
Sales Status (USG)
7,700,000 USD
8,470,000 USD
24,640,000 USD
43,890,000 USD
- 2010
- 2015
- 2020
- 2023
Number of employees
14명
22명
40명
51명
- 2010
- 2015
- 2020
- 2023
Number of Import Licenses for In Vitro Diagnostic Medical Devices
97건
101건
64건
- CLASS I
- CLASS II
- CLASS III
GMP Certifications
GMP총 13개
